Our identification of CoQ10 and its more soluble analog idebenone as partial agonists for both PPARα and PPARγ provides new insight into PPAR molecular and genetic functions, as well as promising new reagents for treating and preventing metabolic disorders. This evidence concerns the gene PPARA and metabolic disease.